A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis

R Richard J. Nowak (Department of Neurology, Yale School of Medicine) M Michael Benatar (University of Miami Miller School of Medicine, Miami) E Emma Ciafaloni (University of Rochester, Rochester, NY) J James F. Howard (University of North Carolina, Chapel Hill) M M. Isabel Leite (University of Oxford, Oxford, United Kingdom) K Kimiaki Utsugisawa J John Vissing (Rigshospitalet, University of Copenhagen, Copenhagen) M Mikhail Rojavin (Amgen, Thousand Oaks, CA) Q Qing Li F Fengming Tang (Amgen, Thousand Oaks, CA) Y Yanping Wu N Nishi Rampal (Amgen, Thousand Oaks, CA) S Sue Cheng (Amgen, Thousand Oaks, CA)